BCM
Bayesian Capital Management’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,399
| Closed | -$636K | – | 870 |
|
|
2022
Q1 | $636K | Buy |
+5,399
| New | +$636K | 0.09% | 313 |
|
|
2021
Q1 | – | Sell |
-20,600
| Closed | -$1.88M | – | 581 |
|
|
2020
Q4 | $1.88M | Sell |
20,600
-8,600
| -29% | -$784K | 0.49% | 47 |
|
|
2020
Q3 | $2.33M | Buy |
29,200
+9,500
| +48% | +$758K | 0.57% | 34 |
|
|
2020
Q2 | $1.36M | Buy |
19,700
+16,600
| +535% | +$1.15M | 0.3% | 87 |
|
|
2020
Q1 | $585K | Sell |
3,100
-18,900
| -86% | -$3.57M | 0.13% | 247 |
|
|
2019
Q4 | $5.13M | Buy |
22,000
+19,100
| +659% | +$4.46M | 0.88% | 12 |
|
|
2019
Q3 | $638K | Buy |
+2,900
| New | +$638K | 0.12% | 229 |
|
|
2018
Q2 | – | Sell |
-12,229
| Closed | -$1.71M | – | 639 |
|
|
2018
Q1 | $1.71M | Buy |
+12,229
| New | +$1.71M | 0.43% | 37 |
|
|
2017
Q4 | – | Sell |
-19,209
| Closed | -$2.1M | – | 594 |
|
|
2017
Q3 | $2.1M | Buy |
19,209
+11,300
| +143% | +$1.24M | 0.5% | 42 |
|
|
2017
Q2 | $935K | Buy |
+7,909
| New | +$935K | 0.34% | 86 |
|
|
2016
Q4 | – | Sell |
-7,812
| Closed | -$942K | – | 624 |
|
|
2016
Q3 | $942K | Buy |
7,812
+4,512
| +137% | +$544K | 0.62% | 26 |
|
|
2016
Q2 | $329K | Sell |
3,300
-3,090
| -48% | -$308K | 0.2% | 211 |
|
|
2016
Q1 | $564K | Buy |
6,390
+272
| +4% | +$24K | 0.53% | 26 |
|
|
2015
Q4 | $483K | Buy |
+6,118
| New | +$483K | 0.69% | 28 |
|